The Antiparkinsonian and Antidyskinetic Mechanisms ofMucuna pruriensin the MPTP-Treated Nonhuman Primate

Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients

(2010) M. Lafreniere-Roula et al.   EXPERIMENTAL NEUROLOGY

The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease

(2010) Gaia Giannicola et al.   EXPERIMENTAL NEUROLOGY

The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys

(2010) Timothy P. Gilmour et al.   EXPERIMENTAL NEUROLOGY

A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias

(2010) Christopher A. Lieu et al.   PARKINSONISM & RELATED DISORDERS

Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys

(2010) Christopher A. Lieu et al.   PARKINSONISM & RELATED DISORDERS

Detection of MPTP-Induced Substantia Nigra Hyperechogenicity in Rhesus Monkeys by Transcranial Ultrasound

(2010) Thyagarajan Subramanian et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

(2009) Valerie Voon et al.   LANCET NEUROLOGY

Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson’s Disease

(2009) Sanjay Kasture et al.   NEUROTOXICITY RESEARCH